RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Angelini Ventures
A

Angelini Ventures portfolio

Angelini Ventures has 14 portfolio companies on record at Recent Funding, with 4 investments in the last 12 months.

Type: Corporate venture.
Portfolio on Recent Funding: 14.
Deals, last 12 months: 4.
Rounds led: 3 of 9.
Capital in their rounds: $517M.
Latest deal: MMI · Oct 8, 2026.
About this page

It is a corporate venture investor based in Rome, IT, founded in 2021. It led 3 of the 9 rounds it joined. Its most recent investment on record is MMI's $125M Series B+ round in October 2026, alongside S3 Ventures and BioStar Capital. By category, its portfolio leans toward Health and bio (14) and Robotics and hardware (2). It has co-invested with Kurma Partners, Kerna Ventures and Indaco Venture Partners, most often Kurma Partners (2 rounds).

About Angelini Ventures

Firm type: Corporate venture.
Headquarters: Rome, IT.
Founded: 2021.
Stages: Seed, Series A.
Sectors: Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Mental Health.
Portfolio companies: 35.
Exits: 0.
Rounds led: 6.

What Angelini Ventures invests in

Angelini Ventures recent investments

How Angelini Ventures invests

StageDealsCapital in rounds
Series B+ 5 56%$337M
Series A 3 33%$135M
Seed 1 11%$45M
YearDealsCapital in rounds
2023 1 11%$38M
2024 1 11%$40M
2025 3 33%$121M
2026 4 44%$318M

Angelini Ventures portfolio companies

CompanyRound with Angelini VenturesTotal raisedLatest raise
MMMI
Health and bio
Series B+ · $125M$310MOct 8, 2026
Series B+
RRougeTx
Health and bio
Series A · $58M · lead$58MOct 6, 2026
Series A
AAptadir Therapeutics
Health and bio
Seed · $45M$45MSep 29, 2026
Seed
EEpicrispr Biotechnologies
Health and bio
Series B+ · $90M$158MAug 11, 2026
Series B+
TTherini Bio
Health and bio
Series A · $39M$56MMay 21, 2026
Series A
NNuevocor
Health and bio
Series B+ · $45M · lead$69MMay 6, 2025
Series B+
NNobi
Health and bio
Series B+ · $37M · lead$41MFeb 4, 2025
Series B+
NNoctrix Health
Health and bio
Series B+ · $40M$73.5MSep 2, 2025
round
FFreya Biosciences
Health and bio
Series A · $38M$38MNov 19, 2024
Series A
AAdcytherix
Health and bio
backerundisclosedOct 16, 2025
Series A
EElkedonia
Health and bio
backer$13MJul 12, 2025
Seed
CCoMind
Health and bio
backerundisclosed—
NNouscom
Health and bio
backer$267.56MOct 19, 2026
Series B+
VVantis
Health and bio
backer$4.58MMar 12, 2025
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 9 rounds on Recent Funding that name Angelini Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Angelini Ventures, which is a subset of its real portfolio. API: /api/v1/investors/angelini-ventures (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy